Skip to main content

AALL1821 A study to compare blinatumomab alone to blinatumomab with nivolumab in patients diagnosed with first relapse B-cell Acute Lymphoblastic Leukemia (B-ALL)

NCT04546399

A study to compare blinatumomab alone to blinatumomab with nivolumab in patients diagnosed with first relapse B-cell Acute Lymphoblastic Leukemia (B-ALL)

Associated Conditions

Leukemia

Principal Investigator

Sponsor

Children's Oncology Group

A study to compare blinatumomab alone to blinatumomab with nivolumab in patients diagnosed with first relapse B-cell Acute Lymphoblastic Leukemia (B-ALL)

This study is currently enrolling.